Linked e-resources
Details
Table of Contents
Foreword
Preface
Anti-ischemic Therapy
Antiaggregant Therapy: New potent P2Y12 inhibitors
Anticoagulation Therapy: Heparins and Factor Xa inhibitors
Secondary prevention in ACS The role of novel oral anticoagulants
American vs European guidelines
Critical appraisal
Triple therapy: Risky but sometimes necessary
Management of bleeding complications.
Preface
Anti-ischemic Therapy
Antiaggregant Therapy: New potent P2Y12 inhibitors
Anticoagulation Therapy: Heparins and Factor Xa inhibitors
Secondary prevention in ACS The role of novel oral anticoagulants
American vs European guidelines
Critical appraisal
Triple therapy: Risky but sometimes necessary
Management of bleeding complications.